Literature DB >> 17698759

Clinical and functional findings in choroideremia due to complete deletion of the CHM gene.

Marco Mura1, Christina Sereda, Monica M Jablonski, Ian M MacDonald, Alessandro Iannaccone.   

Abstract

OBJECTIVE: To report the clinical, functional, and in vivo microanatomic characteristics of a family with choroideremia with a deletion of the entire gene that encodes for the Rab escort protein 1 (CHM).
METHODS: We performed clinical examination, flash electroretinography (ERG), light- and dark-adapted perimetry, and optical coherence tomography; reviewed medical records; and obtained the medical history of the proband and 3 other family members.
RESULTS: At 4 years of age, the proband had a hypopigmented fundus and retinal pigment epithelium mottling, and dark-adapted ERGs were reduced. Severe retinal pigment epithelium and choriocapillaris atrophy developed by 6 years of age, paralleled by a lesser ERG decline. Optical coherence tomography findings showed normal neural retinas overlying mild changes in the retinal pigment epithelium and thinned neural retina with impaired lamination, yet the neural retina was fairly preserved over retinal pigment epithelium and choriocapillaris atrophy. The carrier mother had diffuse elevation of 650-nm dark-adapted thresholds.
CONCLUSIONS: Deletion of the CHM gene causes severe choroideremia. Results of serial ERGs and fundus examinations documented progression first of rod and then of cone disease. Fundus appearance deteriorated rapidly, in excess of the severity of the ERG decline. Optical coherence tomography findings explained this observation, at least in part. CLINICAL RELEVANCE: To our knowledge, this is the earliest clinical, microanatomic, and ERG longitudinal phenotypic documentation in molecularly characterized choroideremia and the first documentation of impaired dark-adapted cone function in carriers. The preservation of the neural retina has mechanistic, prognostic, and therapeutic implications.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17698759     DOI: 10.1001/archopht.125.8.1107

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  24 in total

1.  Transition zones between healthy and diseased retina in choroideremia (CHM) and Stargardt disease (STGD) as compared to retinitis pigmentosa (RP).

Authors:  Margot A Lazow; Donald C Hood; Rithambara Ramachandran; Tomas R Burke; Yi-Zhong Wang; Vivienne C Greenstein; David G Birch
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-12-20       Impact factor: 4.799

2.  Choroidal imaging in inherited retinal disease using the technique of enhanced depth imaging optical coherence tomography.

Authors:  Jonathan Yeoh; Waheeda Rahman; Fred Chen; Claire Hooper; Praveen Patel; Adnan Tufail; Andrew R Webster; Anthony T Moore; Lyndon Dacruz
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-07-17       Impact factor: 3.117

3.  Visual Function at the Atrophic Border in Choroideremia Assessed with Adaptive Optics Microperimetry.

Authors:  William S Tuten; Grace K Vergilio; Gloria J Young; Jean Bennett; Albert M Maguire; Tomas S Aleman; David H Brainard; Jessica I W Morgan
Journal:  Ophthalmol Retina       Date:  2019-05-08

4.  Clinical utility gene card for: choroideremia.

Authors:  Mariya Moosajee; Simon C Ramsden; Graeme C M Black; Miguel C Seabra; Andrew R Webster
Journal:  Eur J Hum Genet       Date:  2013-08-21       Impact factor: 4.246

5.  Topical dorzolamide for treatment of cystoid macular edema in patients with choroideremia.

Authors:  Mohamed A Genead; Jason J McAnany; Gerald A Fishman
Journal:  Retina       Date:  2012-04       Impact factor: 4.256

6.  Ocular coherence tomography findings in a case of choroideremia.

Authors:  Savleen Kaur; Nishant Sachdev
Journal:  Int Ophthalmol       Date:  2013-03-29       Impact factor: 2.031

7.  High-resolution adaptive optics retinal imaging of cellular structure in choroideremia.

Authors:  Jessica I W Morgan; Grace Han; Eva Klinman; William M Maguire; Daniel C Chung; Albert M Maguire; Jean Bennett
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-09-04       Impact factor: 4.799

8.  Natural History of the Central Structural Abnormalities in Choroideremia: A Prospective Cross-Sectional Study.

Authors:  Tomas S Aleman; Grace Han; Leona W Serrano; Nicole M Fuerst; Emily S Charlson; Denise J Pearson; Daniel C Chung; Anastasia Traband; Wei Pan; Gui-Shuang Ying; Jean Bennett; Albert M Maguire; Jessica I W Morgan
Journal:  Ophthalmology       Date:  2016-12-13       Impact factor: 12.079

9.  Choroideremia: analysis of the retina from a female symptomatic carrier.

Authors:  Vera L Bonilha; Karmen M Trzupek; Yong Li; Peter J Francis; Joe G Hollyfield; Mary E Rayborn; Nizar Smaoui; Richard G Weleber
Journal:  Ophthalmic Genet       Date:  2008-09       Impact factor: 1.803

10.  Clinical characteristics of a large choroideremia pedigree carrying a novel CHM mutation.

Authors:  Alex S Huang; Leo A Kim; Amani A Fawzi
Journal:  Arch Ophthalmol       Date:  2012-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.